sponsored
PatientsVille.com Logo

PatientsVille

Nucynta Medical Research Studies

Up-to-date List of Nucynta Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Nucynta Medical Research Studies

Rank Status Study
1 Not yet recruiting A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain
Condition: Pain
Interventions: Drug: Tapentadol prolonged release;   Drug: Morphine prolonged release
Outcome Measures: Proportion of participants classified as responders;   Constipation;   Tolerability
2 Not yet recruiting An Efficacy and Safety Study of Tapentadol in the Treatment of Post-operative Acute Pain Requiring Opiod Treatment in Pediatric Participants
Condition: Acute Pain
Interventions: Drug: Tapentadol 4 mg/mL;   Drug: Tapentadol 20 mg/mL;   Other: Placebo
Outcome Measures: For US: The total amount of supplemental opioid analgesic medication used within the first 12 hours after first intake of investigational medicinal product (IMP) [tapentadol oral solution or placebo] in participants aged from birth to less than 17 years;   For Europe: The total amount of supplemental opioid analgesic (pain killer) medication used within the first 24 hours after first intake of IMP in participants aged from 2 years to less than 18 years;   The total amount of supplemental opioid analgesic medication used within the first 12 hours after the first intake of IMP in participants from 2 years to less than 18 years;   The total amount of supplemental opioid analgesic medication used within the first 24 hours after the first intake of IMP in participants aged from birth to less than 17 years;   The total amount of supplemental opioid analgesic medication received during treatment with IMP over a maximum period of 48 hours after the first dose of IMP;   The total amount of non-opioid analgesics used (irrespective of the indication) during the treatment period (2 days) within the first 24 hours or within the first 12 hours after the first dose of IMP;   Palatability of IMP in participants aged 3 years to less than 18 years assessed using facial 5-point hedonic scale;   Acceptability of IMP in participants aged 3 years to less than 18 years assessed using facial 5-point hedonic scale;   Change from baseline in the Face, Leg, Activity, Cry, and Consolability (FLACC) total score in participants aged less than 3 years;   Change from baseline in the Faces Pain Scale-Revised (FPS-R) pain intensity score in participants aged 6 to less than 12 years;   Change from baseline in the Visual Analog Scale (VAS) pain intensity score in participants aged 12 to less than 18 years;   Clinical Global Impression of Change (CGIC);   Patient Global Impression of Change (PGIC);   Time to receive first and second patient or nurse controlled analgesia after the first dose of IMP;   Time from first dose of IMP until treatment discontinuation due to lack of efficacy
3 Recruiting Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
Conditions: Tumor;   Cancer Pain;   Breakthrough Cancer Pain;   Neuropathic Pain
Interventions: Drug: Morphine;   Drug: Fentanyl;   Drug: Methadone;   Drug: Buprenorphine;   Drug: Oxycodone;   Drug: Hydromorphone;   Drug: Tapentadol
Outcome Measures: Number and duration of episodes of BTcP;   Time to reach the peak of pain in the BTcP;   Maximum intensity of BTcP;   Intensity of pain;   Effect of the treatments

These studies may lead to new treatments and are adding insight into Nucynta etiology and treatment.

A major focus of Nucynta research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Nucynta